World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
87
Citations
21023
World Ranking
13816
National Ranking
7011

Frank M. Balis publication distribution in Medicine in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Medicine in 2026. The highlighted bar marks where Frank M. Balis sits on this spectrum.

101–120 publications: 5 scientists 121–140 publications: 26 scientists 141–160 publications: 73 scientists 161–180 publications: 155 scientists 181–200 publications: 230 scientists 201–220 publications: 363 scientists 221–240 publications: 487 scientists 241–260 publications: 545 scientists 261–280 publications: 722 scientists 281–300 publications: 768 scientists 301–320 publications: 834 scientists 321–340 publications: 895 scientists 341–360 publications: 922 scientists 361–380 publications: 838 scientists 381–400 publications: 861 scientists 401–420 publications: 918 scientists 421–440 publications: 806 scientists 441–460 publications: 771 scientists 461–480 publications: 751 scientists 481–500 publications: 713 scientists 501–520 publications: 617 scientists 521–540 publications: 611 scientists 541–560 publications: 537 scientists 561–580 publications: 504 scientists 581–600 publications: 509 scientists 601–620 publications: 396 scientists 621–640 publications: 386 scientists 641–660 publications: 371 scientists 661–680 publications: 340 scientists 681–700 publications: 336 scientists 701–720 publications: 307 scientists 721–740 publications: 259 scientists 741–760 publications: 230 scientists 761–780 publications: 228 scientists 781–800 publications: 217 scientists 801–820 publications: 204 scientists 821–840 publications: 186 scientists 841–860 publications: 177 scientists 861–880 publications: 155 scientists 881–900 publications: 139 scientists 901–920 publications: 145 scientists 921–940 publications: 116 scientists 941–960 publications: 133 scientists 961–980 publications: 91 scientists 981–1,000 publications: 96 scientists 1,001–1,020 publications: 77 scientists 1,021–1,040 publications: 70 scientists 1,041–1,060 publications: 63 scientists 1,061–1,080 publications: 77 scientists 1,081–1,100 publications: 49 scientists 1,101–1,120 publications: 54 scientists 1,121–1,140 publications: 49 scientists 1,141–1,160 publications: 51 scientists 1,161–1,180 publications: 35 scientists 1,181–1,200 publications: 39 scientists 1,201–1,220 publications: 26 scientists 1,221–1,240 publications: 37 scientists 1,241–1,260 publications: 36 scientists 1,261–1,280 publications: 27 scientists 1,281–1,300 publications: 32 scientists 1,301–1,320 publications: 28 scientists 1,321–1,340 publications: 17 scientists 1,341–1,360 publications: 30 scientists 1,361–1,380 publications: 28 scientists 1,381–1,400 publications: 17 scientists 1,401–1,420 publications: 21 scientists 1,421–1,440 publications: 15 scientists 1,441–1,460 publications: 12 scientists 1,461–1,480 publications: 12 scientists 1,481–1,500 publications: 18 scientists 1,501–1,520 publications: 14 scientists 1,521–1,540 publications: 17 scientists 1,541–1,560 publications: 15 scientists 1,561–1,580 publications: 6 scientists 1,581–1,600 publications: 2 scientists 1,601–1,620 publications: 12 scientists 1,621–1,640 publications: 11 scientists 1,641–1,660 publications: 8 scientists 1,661–1,680 publications: 5 scientists 1,681–1,700 publications: 5 scientists 1,701–1,720 publications: 10 scientists 1,721–1,740 publications: 12 scientists 1,741–1,760 publications: 14 scientists 1,761–1,780 publications: 6 scientists 1,781–1,795 publications: 5 scientists 1,796+ publications: 100 scientists
101 publications 1,796+

This scientist: 353 publications — 28th percentile

28% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 1,796 publications or more.

Frank M. Balis D-index placement in Medicine in 2026

The chart shows the D-index (discipline H-index) distribution of Medicine scientists ranked by Research.com in 2026. The highlighted bar marks where Frank M. Balis sits on this spectrum.

70–71 D-Index: 226 scientists 72–73 D-Index: 391 scientists 74–75 D-Index: 574 scientists 76–77 D-Index: 730 scientists 78–79 D-Index: 891 scientists 80–81 D-Index: 972 scientists 82–83 D-Index: 1,027 scientists 84–85 D-Index: 1,003 scientists 86–87 D-Index: 960 scientists 88–89 D-Index: 970 scientists 90–91 D-Index: 922 scientists 92–93 D-Index: 839 scientists 94–95 D-Index: 808 scientists 96–97 D-Index: 779 scientists 98–99 D-Index: 668 scientists 100–101 D-Index: 611 scientists 102–103 D-Index: 630 scientists 104–105 D-Index: 513 scientists 106–107 D-Index: 541 scientists 108–109 D-Index: 445 scientists 110–111 D-Index: 429 scientists 112–113 D-Index: 400 scientists 114–115 D-Index: 393 scientists 116–117 D-Index: 318 scientists 118–119 D-Index: 302 scientists 120–121 D-Index: 287 scientists 122–123 D-Index: 255 scientists 124–125 D-Index: 256 scientists 126–127 D-Index: 252 scientists 128–129 D-Index: 230 scientists 130–131 D-Index: 179 scientists 132–133 D-Index: 168 scientists 134–135 D-Index: 163 scientists 136–137 D-Index: 159 scientists 138–139 D-Index: 134 scientists 140–141 D-Index: 134 scientists 142–143 D-Index: 118 scientists 144–145 D-Index: 109 scientists 146–147 D-Index: 106 scientists 148–149 D-Index: 74 scientists 150–151 D-Index: 79 scientists 152–153 D-Index: 80 scientists 154–155 D-Index: 87 scientists 156–157 D-Index: 57 scientists 158–159 D-Index: 74 scientists 160–161 D-Index: 69 scientists 162–163 D-Index: 60 scientists 164–165 D-Index: 53 scientists 166–167 D-Index: 39 scientists 168–169 D-Index: 42 scientists 170–171 D-Index: 32 scientists 172–173 D-Index: 39 scientists 174–175 D-Index: 40 scientists 176–177 D-Index: 28 scientists 178–179 D-Index: 19 scientists 180–181 D-Index: 23 scientists 182–183 D-Index: 31 scientists 184–185 D-Index: 18 scientists 186–187 D-Index: 20 scientists 188–189 D-Index: 22 scientists 190–191 D-Index: 13 scientists 192–193 D-Index: 21 scientists 194–195 D-Index: 12 scientists 196–197 D-Index: 12 scientists 198–199 D-Index: 14 scientists 200–201 D-Index: 15 scientists 202–203 D-Index: 13 scientists 204–205 D-Index: 10 scientists 206–207 D-Index: 8 scientists 208–209 D-Index: 4 scientists 210–211 D-Index: 12 scientists 212–213 D-Index: 11 scientists 214–215 D-Index: 10 scientists 216 D-Index: 4 scientists 217+ D-Index: 98 scientists
70 D-Index 217+

This scientist: 87 D-Index — 34th percentile

34% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 217 D-Index or more.

Overview

Frank M. Balis is affiliated with the Children's Hospital of Philadelphia in the United States. Their research spans multiple areas within medicine, with a focus on oncology, pediatrics, molecular biology, and biochemistry.

The primary fields of study covered by their work include:

  • Medicine
  • Biochemistry, Genetics and Molecular Biology

The subfields most frequently associated with their research are:

  • Molecular Biology
  • Pediatrics, Perinatology and Child Health
  • Pulmonary and Respiratory Medicine
  • Oncology
  • Neurology

The topics central to their publications encompass:

  • Neuroblastoma Research and Treatments
  • Renal and related cancers
  • Chemotherapy-induced cardiotoxicity and mitigation
  • Childhood Cancer Survivors' Quality of Life
  • Cancer therapeutics and mechanisms
  • Neonatal Health and Biochemistry
  • Lung Cancer Treatments and Mutations

Representative recent publications by Frank M. Balis include:

  • Phase 1 study of high-dose DFMO, celecoxib, cyclophosphamide and topotecan for patients with relapsed neuroblastoma: a New Approaches to Neuroblastoma Therapy trial, 2024, British Journal of Cancer
  • Activity of Crizotinib in Patients with ALK-Aberrant Relapsed/Refractory Neuroblastoma: A Children's Oncology Group Study (ADVL0912), 2021, Clinical Cancer Research
  • Wilms Tumor (Nephroblastoma), Version 2.2021, NCCN Clinical Practice Guidelines in Oncology, 2021, Journal of the National Comprehensive Cancer Network
  • Safety, tolerability and pharmacokinetics of crizotinib in combination with cytotoxic chemotherapy for pediatric patients with refractory solid tumors or anaplastic large cell lymphoma (ALCL): a Children's Oncology Group phase 1 consortium study (ADVL1212), 2020, Cancer Chemotherapy and Pharmacology
  • An enhanced recovery after surgery protocol in children who undergo nephrectomy for Wilms tumor safely shortens hospital stay, 2022, Journal of Pediatric Surgery

Publication venues in which Balis has frequently contributed include:

  • Pediatric Blood & Cancer
  • Cancer Chemotherapy and Pharmacology
  • Journal of the National Comprehensive Cancer Network
  • Clinical Cancer Research
  • British Journal of Cancer

Frequent co-authors collaborating with Frank M. Balis are:

  • Elizabeth Fox
  • Brenda J. Weigel
  • Smita Bhatia
  • Charles G. Minard
  • Yaël P. Mossé

Best Publications

  • Safety and activity of crizotinib for paediatric patients with refractory solid tumours or anaplastic large-cell lymphoma: a Children's Oncology Group phase 1 consortium study

    Yael P Mossé;Megan S Lim;Stephan D Voss;Keith Wilner

  • PTERIDINE NUCLEOTIDE ANALOG AS FLUORESCENT DNA

    Hawkins Mary E;Pfleiderer Wolfgang;Davis Michael Dean;Balis Frank

  • Effect of Continuous Intravenous Infusion of Zidovudine (AZT) in Children with Symptomatic HIV Infection

    Pizzo Pa;Eddy J;Falloon J;Balis Fm

  • Dose-adjusted EPOCH chemotherapy for untreated large B-cell lymphomas: a pharmacodynamic approach with high efficacy

    Wyndham H. Wilson;Michael L. Grossbard;Stefania Pittaluga;Diane Cole

  • High-Dose Methotrexate-Induced Nephrotoxicity in Patients with Osteosarcoma: Incidence, Treatment, and Outcome

    Brigitte C. Widemann;Frank M. Balis;Beate Kempf-Bielack;Stefan Bielack

  • Differences in cerebrospinal fluid penetration of corticosteroids: possible relationship to the prevention of meningeal leukemia.

    Frank M. Balis;Cynthia M. Lester;George P. Chrousos;Richard L. Heideman

  • Trimetrexate for the treatment of Pneumocystis carinii pneumonia in patients with the acquired immunodeficiency syndrome.

    C J Allegra;B A Chabner;C U Tuazon;D Ogata-Arakaki

  • Dideoxyinosine in children with symptomatic human immunodeficiency virus infection

    Karina M. Butler;Robert N. Husson;Frank M. Balis;Pim Brouwers

  • Randomized trial of the cardioprotective agent ICRF-187 in pediatric sarcoma patients treated with doxorubicin.

    L H Wexler;M P Andrich;D Venzon;S L Berg

  • NF1 plexiform neurofibroma growth rate by volumetric MRI: Relationship to age and body weight

    E. Dombi;J. Solomon;A. J. Gillespie;E. Fox

  • Central nervous system pharmacology of antileukemic drugs.

    Frank M. Balis;David G. Poplack

  • Fluorescence Properties of Pteridine Nucleoside Analogs as Monomers and Incorporated into Oligonucleotides

    Mary E. Hawkins;Wolfgang Pfleiderer;Frank M. Balis;Denise Porter

  • Fluconazole Penetration into Cerebrospinal Fluid: Implications for Treating Fungal Infections of the Central Nervous System

    Carola A. S. Arndt;Thomas J. Walsh;Cynthia Lester McCully;Frank M. Balis

  • Phase I and pharmacokinetic evaluation of all-trans-retinoic acid in pediatric patients with cancer.

    M A Smith;P C Adamson;F M Balis;J Feusner

  • A pharmacodynamic study of docetaxel in combination with the P-glycoprotein antagonist tariquidar (XR9576) in patients with lung, ovarian, and cervical cancer.

    Ronan J. Kelly;Deborah Draper;Clara C. Chen;Robert W. Robey

  • Loss of Smad3 in acute T-cell lymphoblastic leukemia.

    Lawrence A. Wolfraim;Tania M. Fernandez;Mizuko Mamura;Walter L. Fuller

  • Clinical Trial Design for Target-Based Therapy

    Elizabeth Fox;Gregory A. Curt;Frank M. Balis

  • Phase I Trial and Pharmacokinetic Study of the Farnesyltransferase Inhibitor Tipifarnib in Children With Refractory Solid Tumors or Neurofibromatosis Type I and Plexiform Neurofibromas

    Brigitte C. Widemann;Wanda L. Salzer;Robert J. Arceci;Susan M. Blaney

  • Plasma and cerebrospinal fluid pharmacokinetics of intravenous temozolomide in non-human primates.

    Mahendra Patel;Cynthia McCully;Karen Godwin;Frank M Balis

  • Effect of continuous intravenous infusion of zidovudine (AZT) in children with symptomatic HIV infection

    PA Pizzo;J Eddy;J Falloon;FM Balis

Frequent Co-Authors

David G. Poplack
David G. Poplack Baylor College of Medicine
Peter C. Adamson
Peter C. Adamson Children's Hospital of Philadelphia
Seth M. Steinberg
Seth M. Steinberg National Institutes of Health
Susan M. Blaney
Susan M. Blaney Baylor College of Medicine
Philip A. Pizzo
Philip A. Pizzo Stanford University
David Venzon
David Venzon National Institutes of Health
Roger J. Packer
Roger J. Packer Children’s National Health System
Tito Fojo
Tito Fojo Columbia University
John M. Maris
John M. Maris Children's Hospital of Philadelphia
Wolfgang Pfleiderer
Wolfgang Pfleiderer University of Konstanz

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

As interest in healthcare careers grows, many students are exploring online education as a flexible path into the industry. Accredited online programs now make it easier to prepare for roles in medicine, nursing, and health administration—even while balancing work and family commitments.

Several in-demand fields offer affordable and convenient online study options. For example, a him associate degree online is ideal for those interested in managing patient data, medical records, and healthcare IT systems. If you prefer working with medical billing and insurance processes, obtaining a medical billing and coding certification online can quickly open doors to entry-level roles.

For those seeking advanced clinical responsibilities, consider online nurse practitioner programs, which prepare nurses for primary care and specialty roles. Students looking for a cost-effective route into nursing will find a variety of cheap online nursing programs to start or further their careers.

These online healthcare degrees and certifications offer practical, affordable paths toward rewarding positions in the growing medical field.

Best Scientists Citing Frank M. Balis

Trending Scientists

Recently Published Articles